Assembly Biosciences (ASMB) Change in Accured Expenses (2010 - 2026)

Assembly Biosciences' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$5.1 million for Q1 2026.

• On a quarterly basis, Change in Accured Expenses fell 11.51% year-over-year to -$5.1 million in Q1 2026; TTM through Mar 2026 was $362000.0, a 44.22% increase from a year earlier, with the FY2025 full-year figure at $887000.0, down 20.66% from the prior year.
• Change in Accured Expenses eased to -$5.1 million in Q1 2026 per ASMB's latest filing, from $2.0 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $2.3 million in Q3 2025 and bottomed at -$5.1 million in Q1 2026.
• The 5-year median for Change in Accured Expenses is $1.1 million (2025), against an average of -$246647.1.
• Across the five-year window, Change in Accured Expenses sank 131.79% in 2023 and surged 490.07% in 2024, its largest moves.
• Year by year, Change in Accured Expenses stood at $1.6 million in 2022, then advanced by 13.29% to $1.9 million in 2023, then gained by 12.86% to $2.1 million in 2024, then retreated by 3.62% to $2.0 million in 2025, then sank by 351.61% to -$5.1 million in 2026.
• Per Business Quant, the three latest ASMB Change in Accured Expenses figures stand at -$5.1 million (Q1 2026), $2.0 million (Q4 2025), and $2.3 million (Q3 2025).